We are live on ! Find out more
AJ

Ashburton (Jersey) Portfolio holdings

AUM $227M
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$210M
AUM Growth
+$13.8M
Cap. Flow
-$10.4M
Cap. Flow %
-4.95%
Top 10 Hldgs %
84.52%
Holding
114
New
59
Increased
25
Reduced
11
Closed
8
Avg Time Held
3.9 quarters
Top 10 Avg Time Held
11.7 quarters
Top 20 Avg Time Held
7.4 quarters

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$4.93M
2
T icon
AT&T
T
+$4.82M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$1.01M
4
MOMO icon
Hello Group
MOMO
+$505K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$410K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$23M
2
PFE icon
Pfizer
PFE
+$2.3M
3
AAPL icon
Apple
AAPL
+$857K
4
HD icon
Home Depot
HD
+$356K
5
MSFT icon
Microsoft
MSFT
+$254K

Sector Composition

Rank Sector Weight
1 Healthcare 22.58%
2 Technology 21.14%
3 Financials 18.98%
4 Communication Services 18.62%
5 Consumer Discretionary 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CHKP icon
26
Check Point Software Technologies
CHKP
$13.7B
$507K 0.24%
2,563
+38
+2% +$4.49K
2018 Q2
4 quarters
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.11T
$422K 0.2%
+1,981
New +$410K
2019 Q2
0 quarters
NFLX icon
28
Netflix
NFLX
$294B
$393K 0.19%
10,700
+2,800
+35% +$101K
2018 Q2
4 quarters
TJX icon
29
TJX Companies
TJX
$156B
$360K 0.17%
6,800
+940
+16% +$50K
2019 Q1
1 quarter
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$322K 0.15%
1,100
– –
2015 Q4
14 quarters
NVDA icon
31
NVIDIA
NVDA
$5.46T
$261K 0.12%
63,600
+10,800
+20% +$44.8K
2017 Q3
7 quarters
SBUX icon
32
Starbucks
SBUX
$105B
$226K 0.11%
2,693
+1,833
+213% +$144K
2018 Q2
4 quarters
SCHW icon
33
Charles Schwab
SCHW
$168B
$156K 0.07%
3,885
+1,530
+65% +$66.7K
2018 Q3
3 quarters
RY icon
34
Royal Bank of Canada
RY
$267B
$148K 0.07%
+1,862
New +$146K
2019 Q2
0 quarters
MCD icon
35
McDonald's
MCD
$167B
$137K 0.07%
660
+405
+159% +$80.2K
2018 Q4
2 quarters
VZ icon
36
Verizon
VZ
$178B
$134K 0.06%
+2,351
New +$135K
2019 Q2
0 quarters
XOM icon
37
ExxonMobil
XOM
$708B
$129K 0.06%
1,682
+1,302
+343% +$101K
2015 Q4
14 quarters
PG icon
38
Procter & Gamble
PG
$356B
$119K 0.06%
+1,082
New +$115K
2019 Q2
0 quarters
HTH icon
39
Hilltop Holdings
HTH
$2.1B
$117K 0.06%
+5,503
New +$111K
2019 Q2
0 quarters
PEP icon
40
PepsiCo
PEP
$173B
$112K 0.05%
+853
New +$109K
2019 Q2
0 quarters
ECHO icon
41
EchoStar
ECHO
$27.7B
$107K 0.05%
+2,981
New +$99.3K
2019 Q2
0 quarters
WFC icon
42
Wells Fargo
WFC
$252B
$100K 0.05%
2,121
+821
+63% +$38.4K
2018 Q2
4 quarters
DUK icon
43
Duke Energy
DUK
$91.8B
$98K 0.05%
+1,111
New +$98.2K
2019 Q2
0 quarters
D icon
44
Dominion Energy
D
$54.9B
$94K 0.04%
+1,220
New +$93K
2019 Q2
0 quarters
INTC icon
45
Intel
INTC
$536B
$93K 0.04%
+1,934
New +$95.9K
2019 Q2
0 quarters
C icon
46
Citigroup
C
$221B
$90K 0.04%
+1,287
New +$86.1K
2019 Q2
0 quarters
QCOM icon
47
Qualcomm
QCOM
$186B
$83K 0.04%
+1,086
New +$79.5K
2019 Q2
0 quarters
ABBV icon
48
AbbVie
ABBV
$497B
$80K 0.04%
+1,100
New +$86.5K
2019 Q2
0 quarters
IRM icon
49
Iron Mountain
IRM
$34.3B
$76K 0.04%
+2,436
New +$79.8K
2019 Q2
0 quarters
AGN
50
DELISTED
Allergan plc
AGN
$74K 0.04%
1,553
-165,835
-99% -$23M
2018 Q4
2 quarters

Similar funds

Ashburton (Jersey)'s Q2 2019 Portfolio in Review

As of Q2 2019, Ashburton (Jersey) held 114 positions worth $210M, up 7% from $197M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Ashburton (Jersey) withdrew a net $10.4M in Q2 2019, closing 8 positions and reducing 11 holdings. Its most notable exit was Pfizer, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Ashburton (Jersey) opened a new position in Hello Group worth $544K.

  • Ashburton (Jersey)'s largest Q2 2019 buy was Hello Group: 15,200 shares worth $544K.
  • Ashburton (Jersey) added most to Medtronic in Q2 2019, an estimated $4.93M increase.
  • Ashburton (Jersey)'s biggest Q2 2019 reduction was Allergan plc, cutting an estimated $23M.
  • Ashburton (Jersey) fully exited Pfizer in Q2 2019, selling an estimated $2.3M.
  • Ashburton (Jersey)'s ten largest holdings make up 85% of its $210M portfolio in Q2 2019.
  • Ashburton (Jersey) opened 59 new positions and closed 8 in Q2 2019.
  • Ashburton (Jersey)'s portfolio value rose 7% quarter-over-quarter to $210M.

Based on Ashburton (Jersey)'s 13F filing for Q2 2019, filed 26 Jul 2019.